欧洲慢性阻塞性肺疾病指南：展望未来。
Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.
机构信息
Pneumology Department, University Hospital Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Cochin (AP-HP), University Paris Descartes (EA2511), Paris, France.
出版信息
Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1.
Abstract
Clinical practice guidelines are ubiquitous and are developed to provide recommendations for the management of many diseases, including chronic obstructive pulmonary disease. The development of these guidelines is burdensome, demanding a significant investment of time and money. In Europe, the majority of countries develop their own national guidelines, despite the potential for overlap or duplication of effort. A concerted effort and consolidation of resources between countries may alleviate the resource-intensity of maintaining individual national guidelines. Despite significant resource investment into the development and maintenance of clinical practice guidelines, their implementation is suboptimal. Effective strategies of guideline dissemination must be given more consideration, to ensure adequate implementation and improved patient care management in the future.
摘要
临床实践指南无处不在，旨在为许多疾病的管理提供建议，包括慢性阻塞性肺疾病。这些指南的制定非常繁琐，需要投入大量的时间和资金。在欧洲，大多数国家都制定了自己的国家指南，尽管存在重叠或重复劳动的可能性。各国之间的协同努力和资源整合可能会减轻维持个别国家指南所需的资源密集度。尽管在制定和维护临床实践指南方面投入了大量资源，但它们的实施效果并不理想。必须更加重视有效的指南传播策略，以确保未来的充分实施和改善患者护理管理。
相似文献
1
Chronic obstructive pulmonary disease guidelines in Europe: a look into the future.欧洲慢性阻塞性肺疾病指南：展望未来。
Respir Res. 2018 Jan 18;19(1):11. doi: 10.1186/s12931-018-0715-1.
2
Adaptation, evaluation, and updating of guidelines: article 14 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.指南的修订、评估和更新：COPD 指南制定中的整合和协调工作第 14 条。美国胸科学会/欧洲呼吸学会工作组的官方报告。
Proc Am Thorac Soc. 2012 Dec;9(5):304-10. doi: 10.1513/pats.201208-067ST.
3
Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.确定目标受众：这些指南针对谁？：COPD 指南制定中的综合和协调工作。美国胸科学会/欧洲呼吸学会联合工作组报告第 1 条。
Proc Am Thorac Soc. 2012 Dec;9(5):219-24. doi: 10.1513/pats.201208-054ST.
4
Disseminating and implementing guidelines: article 13 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.推广和实施指南：COPD 指南制定中整合和协调工作的第 13 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):298-303. doi: 10.1513/pats.201208-066ST.
5
Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.将成本效益、可负担性和资源影响因素纳入指南制定中：COPD 指南制定中整合和协调工作的第 6 条。美国胸科学会/欧洲呼吸学会官方研讨会报告。
Proc Am Thorac Soc. 2012 Dec;9(5):251-5. doi: 10.1513/pats.201208-059ST.
6
How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.如何在指南制定中整合多种合并症：COPD 指南制定中整合和协调工作的第 10 条。美国胸科学会/欧洲呼吸学会工作组报告。
Proc Am Thorac Soc. 2012 Dec;9(5):274-81. doi: 10.1513/pats.201208-063ST.
7
Guidelines for the management of chronic obstructive pulmonary disease.慢性阻塞性肺疾病管理指南
Respir Med. 2002 Aug;96 Suppl C:S11-6. doi: 10.1016/s0954-6111(02)80029-4.
8
Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines.澳大利亚在国家指南发布后对慢性阻塞性肺疾病的管理。
Intern Med J. 2011 Mar;41(3):263-70. doi: 10.1111/j.1445-5994.2009.02133.x.
9
[Recommendations of Polish Society of Lung Diseases about diagnosis and therapy of chronic obstructive pulmonary disease (COPD)].[波兰肺病学会关于慢性阻塞性肺疾病（COPD）诊断与治疗的建议]
Pneumonol Alergol Pol. 2010;78(5):318-47.
10
Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.持续应对慢性阻塞性肺疾病国际医师调查：12个国家医师对慢性阻塞性肺疾病管理指南的认知与应用
Int J Chron Obstruct Pulmon Dis. 2014 Dec 30;10:39-55. doi: 10.2147/COPD.S70162. eCollection 2015.
引用本文的文献
1
Perspectives and Attitudes of General Practitioners Towards Pharmacological and Non-Pharmacological COPD Management in a Belgian Primary Care Setting: A Qualitative Study.全科医生在比利时初级医疗环境中对 COPD 药物和非药物管理的观点和态度：一项定性研究。
Int J Chron Obstruct Pulmon Dis. 2023 Sep 25;18:2105-2115. doi: 10.2147/COPD.S423279. eCollection 2023.
2
Cost-consequence analysis of COPD treatment according to NICE and GOLD recommendations compared with current clinical practice in the UK.根据 NICE 和 GOLD 建议与英国当前临床实践对 COPD 治疗进行成本-效果分析。
BMJ Open. 2022 Jun 3;12(6):e059158. doi: 10.1136/bmjopen-2021-059158.
3
Differences in Baseline Characteristics and Access to Treatment of Newly Diagnosed Patients With IPF in the EMPIRE Countries.EMPIRE国家中初诊特发性肺纤维化患者的基线特征及治疗可及性差异。
Front Med (Lausanne). 2021 Dec 23;8:729203. doi: 10.3389/fmed.2021.729203. eCollection 2021.
4
Individual trajectory-based care for COPD: getting closer, but not there yet.慢性阻塞性肺疾病基于个体轨迹的照护：正在接近目标，但尚未达成。
ERJ Open Res. 2021 Dec 13;7(4). doi: 10.1183/23120541.00451-2021. eCollection 2021 Oct.
5
Gaps in COPD Guidelines of Low- and Middle-Income Countries: A Systematic Scoping Review.中低收入国家 COPD 指南中的差距：系统范围综述。
Chest. 2021 Feb;159(2):575-584. doi: 10.1016/j.chest.2020.09.260. Epub 2020 Oct 8.
6
Understanding resource utilization and mortality in COPD to support policy making: A microsimulation study.了解 COPD 中的资源利用和死亡率以支持政策制定：一项微观模拟研究。
PLoS One. 2020 Aug 20;15(8):e0236559. doi: 10.1371/journal.pone.0236559. eCollection 2020.
7
Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients.慢性阻塞性肺疾病患者心血管合并症的管理
J Thorac Dis. 2020 May;12(5):2791-2802. doi: 10.21037/jtd.2020.03.60.
8
Chronic obstructive pulmonary disease (COPD) in Spain and the different aspects of its social impact: a multidisciplinary opinion document.西班牙的慢性阻塞性肺疾病（COPD）及其社会影响的不同方面：一份多学科意见书
Rev Esp Quimioter. 2020 Feb;33(1):49-67. doi: 10.37201/req/2064.2019. Epub 2020 Jan 14.
9
Airway epithelial cell differentiation relies on deficient Hedgehog signalling in COPD.气道上皮细胞分化依赖于 COPD 中 Hedgehog 信号通路的缺陷。
EBioMedicine. 2020 Jan;51:102572. doi: 10.1016/j.ebiom.2019.11.033. Epub 2019 Dec 23.
10
Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis.类风湿关节炎相关慢性阻塞性肺疾病：系统评价和荟萃分析。
Respir Res. 2019 Jul 9;20(1):144. doi: 10.1186/s12931-019-1123-x.
本文引用的文献
1
Russian guidelines for the management of COPD: algorithm of pharmacologic treatment.俄罗斯慢性阻塞性肺疾病管理指南：药物治疗算法
Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:183-187. doi: 10.2147/COPD.S153770. eCollection 2018.
2
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.慢性阻塞性肺疾病（COPD）加重的预防：欧洲呼吸学会/美国胸科学会指南。
Eur Respir J. 2017 Sep 9;50(3). doi: 10.1183/13993003.02265-2016. Print 2017 Sep.
3
A Comparative Analysis of Pulmonary and Critical Care Medicine Guideline Development Methodologies.肺与重症医学指南制定方法的比较分析
Am J Respir Crit Care Med. 2017 Sep 1;196(5):621-627. doi: 10.1164/rccm.201705-0926OC.
4
New guidelines for acute COPD exacerbations.慢性阻塞性肺疾病急性加重的新指南。
Rev Mal Respir. 2017 Apr;34(4):279-281. doi: 10.1016/j.rmr.2017.05.001.
5
Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.《2017年西班牙慢性阻塞性肺疾病管理指南（GesEPOC）。稳定期的药物治疗》
Arch Bronconeumol. 2017 Jun;53(6):324-335. doi: 10.1016/j.arbres.2017.03.018. Epub 2017 May 3.
6
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.COPD 加重的管理：欧洲呼吸学会/美国胸科学会指南。
Eur Respir J. 2017 Mar 15;49(3). doi: 10.1183/13993003.00791-2016. Print 2017 Mar.
7
A new two-step algorithm for the treatment of COPD.一种治疗慢性阻塞性肺疾病（COPD）的新两步算法。
Eur Respir J. 2017 Feb 8;49(2). doi: 10.1183/13993003.02200-2016. Print 2017 Feb.
8
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略：诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
9
Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française.稳定期慢性阻塞性肺疾病的药物治疗优化。法国语言学会肺病学分会的建议
Rev Mal Respir. 2016 Dec;33(10):911-936. doi: 10.1016/j.rmr.2016.10.004. Epub 2016 Nov 25.
10
Eligibility of real-life patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy.慢性阻塞性肺疾病（COPD）真实世界患者纳入吸入长效支气管扩张剂治疗试验的资格。
Respir Res. 2016 Sep 23;17(1):120. doi: 10.1186/s12931-016-0433-5.
Zotero 插件